Inventor

Maria Emilia Di Francesco

Inventor
Houston, TX, US

Overview

26→
Patents
2007–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 26 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes23%
C07KPeptides4%
C07BGeneral methods of organic chemistry3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C07HSugars1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
10,800,769Heterocyclic inhibitors of ATR kinase202010,800,774Heterocyclic inhibitors of ATR kinase202010,766,892GLS1 inhibitors for treating disease202010,745,420Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase202010,421,765Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase201910,392,376Heterocyclic inhibitors of ATR kinase201910,363,261Enolase inhibitors and methods of treatment therewith201910,363,248Salts of heterocyclic modulators of HIF activity for treatment of disease201910,344,025GLS1 inhibitors for treating disease201910,208,059Heterocyclic modulators of HIF activity for treatment of disease20199,809,588'GLS1 inhibitors for treating disease'20179,663,504'Salts of heterocyclic modulators of HIF activity for treatment of disease'20179,598,405'Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors'20179,487,504'Imidazolyl analogs as syk inhibitors'20169,290,490'Aminopyrimidines as Syk inhibitors'20169,216,173'2-Pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors'20159,145,391'Bipyridylaminopyridines as Syk inhibitors'20159,120,785'Pyridyl aminopyridines as Syk inhibitors'20159,006,444'Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors'20158,927,569'Macrocyclic compounds as antiviral agents'20158,551,984'Aminopyrimidines as SYK inhibitors'20138,377,873'HCV NS3 protease inhibitors'20138,183,216'Nucleoside derivatives as inhibitors of viral polymerases'20128,178,520'Macrocyclic compounds as antiviral agents'20127,459,452'Dihydroxypyrimidine carboxamide inhibitors of HIV integrase'20087,232,819'Dihydroxypyrimidine carboxamide inhibitors of HIV integrase'2007

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2007–2013Patents assigned to ANGELETTI P IST RICHERCHE BIO (5)· patent assignee history
2007–2015Based in Rome, IT· patent location history
2012–2016Patents assigned to DI FRANCESCO MARIA EMILIA (9)· patent assignee history
2012Based in Pomezia, IT· patent location history
2013–2017Patents assigned to MERCK SHARP & DOHME (10)· patent assignee history
2013–2016Patents assigned to ALTMAN MICHAEL D (5)· patent assignee history
2013Based in Brookline, MA, US· patent location history
2015–2020Based in Houston, TX, US· patent location history
2017–2020Patents assigned to UNIV TEXAS (12)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV TEXAS122017–2020
MERCK SHARP & DOHME102013–2017
DI FRANCESCO MARIA EMILIAself92012–2016
ALTMAN MICHAEL D52013–2016
ANGELETTI P IST RICHERCHE BIO52007–2013
Locations
LocationPatentsSpan
Houston, Texas, US192015–2020
Rome, IT52007–2015
Brookline, Massachusetts, US12013
Pomezia, IT12012